Does TAPENTADOL Cause Malignant neoplasm progression? 77 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Malignant neoplasm progression have been filed in association with TAPENTADOL (Nucynta). This represents 0.3% of all adverse event reports for TAPENTADOL.
77
Reports of Malignant neoplasm progression with TAPENTADOL
0.3%
of all TAPENTADOL reports
57
Deaths
22
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TAPENTADOL?
Of the 77 reports, 57 (74.0%) resulted in death, 22 (28.6%) required hospitalization, and 3 (3.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAPENTADOL. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does TAPENTADOL Cause?
Death (11,560)
Toxicity to various agents (9,617)
Overdose (5,843)
Drug abuse (1,566)
Drug dependence (1,019)
Drug withdrawal syndrome neonatal (945)
Accidental overdose (693)
Drug ineffective (633)
Pain (436)
Nausea (434)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TAPENTADOL Alternatives Have Lower Malignant neoplasm progression Risk?
TAPENTADOL vs TAPINAROF
TAPENTADOL vs TARCEVA
TAPENTADOL vs TARLATAMAB
TAPENTADOL vs TARLATAMAB-DLLE
TAPENTADOL vs TASIGNA